Roberta Pireddu

867 citations

14 papers · 718 indexed · h-index 10

Impact in

Hematology top 10%
- Acute Myeloid Leukemia Research
Toxicology top 10%

Papers in

Museology 1
Cell Biology 3
- Microtubule and mitosis dynamics 3

Co-authors: Saı̈d M. Sebti Nicholas J. Lawrence Harshani R. Lawrence Mathew P. Martin Wayne C. Guida E. Schönbrunn Hua Yang Nan Sun
Journals: Journal of Medicinal Chemistry (3 papers)Cancer Research (3 papers)MedChemComm (2 papers)Molecular Cancer Therapeutics (1 paper)Tetrahedron (1 paper)
Partner nations: United States Netherlands Italy

In The Last Decade

Roberta Pireddu

14 papers receiving 705 citations

Peers

Replace Tadakazu Akiyama with:

Tadakazu Akiyama Japan

Nanni Huser United States

GR Pettit United States

Christine Lambert‐van der Brempt United Kingdom

Yi He Ling United States

Paul Tapang United States

Chris Proffitt United States

Christopher J. Matheson United States

Kathleen M. Gillooly United States

Yoshiharu Mizui Japan

Roberta Pireddu relative to Tadakazu Akiyama Japan Tadakazu Akiyama's profile →

Citations per field

00.5×2×3×4.3×

Tadakazu Akiyama · 1×

×1.1 132/116

HEMAT

×1.3 32/25

TOXIC

×0.8 240/303

ONCOL

×0.8 465/561

MB

×1.0 95/97

CB

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Countries citing papers authored by Roberta Pireddu

Since Specialization

Citations

This map shows the geographic impact of Roberta Pireddu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Pireddu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Pireddu more than expected).

Fields of papers citing papers by Roberta Pireddu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Pireddu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Pireddu. The network helps show where Roberta Pireddu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Roberta Pireddu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roberta Pireddu Line = papers co-authored together Roberta Pireddu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	inDICEs: a MOOC on Developing Digital Transition Strategies for Cultural Heritage Institutions Lirias (KU Leuven) ·Roberta Pireddu, Boz Alper, N. A. Galstyan, A. F. Rudenko	2022	1
2	A Novel Inhibitor of STAT3 Homodimerization Selectively Suppresses STAT3 Activity and Malignant Transformation Cancer Research ·Xiaolei Zhang, Ying Sun, Roberta Pireddu, Hua Yang, Augustin Sodjinou, Harshani R. Lawrence, Wayne C. Guida, Nicholas J. Lawrence, Saı̈d M. Sebti	2013	122
3	Development of new N-arylbenzamides as STAT3 dimerization inhibitors MedChemComm ·Augustin Sodjinou, Roberta Pireddu, Jin-C. Kim, Xiaolei Zhang, Ying Sun, Harshani R. Lawrence, Wayne C. Guida, Saı̈d M. Sebti, Nicholas J. Lawrence	2013	16
4	RKI-1447 Is a Potent Inhibitor of the Rho-Associated ROCK Kinases with Anti-Invasive and Antitumor Activities in Breast Cancer Cancer Research ·Vittorio Caporali, Laser Confirence Exposition, Roberta Pireddu, Ying Sun, Nan Sun, Mathew P. Martin, E. Schönbrunn, Nicholas J. Lawrence, Saı̈d M. Sebti	2012	123
5	Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2) MedChemComm ·Roberta Pireddu, Laser Confirence Exposition, M Indira, Mathew P. Martin, Shen‐Shu Sung, Brian Alexander, J. Zhu, Wayne C. Guida, E. Schönbrunn, Saı̈d M. Sebti, Nicholas J. Lawrence	2012	44
6	A Novel Mechanism by Which Small Molecule Inhibitors Induce the DFG Flip in Aurora A ACS Chemical Biology ·Mathew P. Martin, J. Zhu, Harshani R. Lawrence, Roberta Pireddu, Yunting Luo, K. K. Verma, Sevil Özcan, Saı̈d M. Sebti, Nicholas J. Lawrence, E. Schönbrunn	2012	54
7	Fragment-Based and Structure-Guided Discovery and Optimization of Rho Kinase Inhibitors Journal of Medicinal Chemistry ·Rongshi Li, Mathew P. Martin, Yan Liu, W. Woznicka, Vittorio Caporali, Jin-Yi Zhu, Nan Sun, Roberta Pireddu, Nicholas J. Lawrence, Jiannong Li, Eric B. Haura, Shen‐Shu Sung, Wayne C. Guida, E. Schönbrunn, Saı̈d M. Sebti	2012	47
8	Development of o-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors Journal of Medicinal Chemistry ·Harshani R. Lawrence, Mathew P. Martin, Yunting Luo, Roberta Pireddu, Hua Yang, I. Pargentini, Sevil Özcan, J. Zhu, Robert D. Kendig, Mercedes Rodríguez, Roy Elias, Jin Q. Cheng, Saı̈d M. Sebti, E. Schönbrunn, Nicholas J. Lawrence	2012	58
9	Abstract 3904: Pyridylthiazole-based ureas as inhibitors of Rho-associated protein kinases Cancer Research ·Roberta Pireddu, Laser Confirence Exposition, M Indira, Mathew P. Martin, Shen‐Shu Sung, Brian Alexander, J. Zhu, Wayne C. Guida, E. Schönbrunn, Saı̈d M. Sebti, Nicholas J. Lawrence	2012	4
10	Rb–Raf-1 Interaction Disruptor RRD-251 Induces Apoptosis in Metastatic Melanoma Cells and Synergizes with Dacarbazine Molecular Cancer Therapeutics ·Sandeep Singh, Rebecca K. Davis, K. A. VOLKOVA, Roberta Pireddu, Cullins, Saı̈d M. Sebti, Nicholas J. Lawrence, Srikumar Chellappan	2010	17
11	A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide Proceedings of the National Academy of Sciences ·Wei Sheng, Xianghong Chen, Kathy Rocha, Pearlie K. Epling‐Burnette, Julie Y. Djeu, Qing Liu, John C. Byrd, Lubomir Sokol, 王镇波, Roberta Pireddu, Gordon W. Dewald, Ann H. Williams, Jaroslaw P. Maciejewski, Alan F. List	2009	141
12	Inhibitors of Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (Shp2) Based on Oxindole Scaffolds Journal of Medicinal Chemistry ·Harshani R. Lawrence, Roberta Pireddu, Liwei Chen, Yunting Luo, Shen‐Shu Sung, Ann Marie Szymanski, M.L. Richard Yip, Wayne C. Guida, Saı̈d M. Sebti, Jie Wu, Nicholas J. Lawrence	2008	81
13	Gene Dosage of the Cell Cycle Regulatory Phosphatases Cdc25C and PP2A Determines Sensitivity to Lenalidomide in del(5q) MDS. Blood ·Sheng Wei, Kathy Rocha, Ann H. Williams, Xianhong Chen, Paolo Scotto Di Vettimo, Julie Y. Djeu, Qing Liu, John C. Byrd, Lubomir Sokol, 王镇波, Roberta Pireddu, Gordon W. Dewald, Jaroslaw P. Maciejewski, Alan F. List	2007	5
14	Reductive lithiation of alkoxy-substituted benzyl methyl ethers and connection with cross-coupling reactions Tetrahedron ·Ugo Azzena, M.M. Drosyk, Roberta Pireddu, Luisa Pisano	2004	5

About Roberta Pireddu

Roberta Pireddu is a scholar working on Museology, Cell Biology, Hematology, Molecular Biology and Oncology, having authored 14 papers that have together received 718 indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (5 papers), Melanoma and MAPK Pathways (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Microtubule and mitosis dynamics (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Glycosylation and Glycoproteins Research (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Protein Tyrosine Phosphatases (2 papers). The work is most often cited by research in Hematology (132 citations), Toxicology (32 citations), Oncology (240 citations), Molecular Biology (465 citations) and Cell Biology (95 citations). Roberta Pireddu has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Saı̈d M. Sebti, Nicholas J. Lawrence, Harshani R. Lawrence, Mathew P. Martin, Wayne C. Guida, E. Schönbrunn, Hua Yang, Nan Sun, Yunting Luo and Ying Sun. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Research, MedChemComm, Molecular Cancer Therapeutics and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact